STRUCTURAL CHARACTERIZATION OF CONTAMINANTS FOUND IN COMMERCIAL PREPARATIONS OF MELATONIN - SIMILARITIES TO CASE-RELATED COMPOUNDS FROM L-TRYPTOPHAN ASSOCIATED WITH EOSINOPHILIA-MYALGIA-SYNDROME
Bl. Williamson et al., STRUCTURAL CHARACTERIZATION OF CONTAMINANTS FOUND IN COMMERCIAL PREPARATIONS OF MELATONIN - SIMILARITIES TO CASE-RELATED COMPOUNDS FROM L-TRYPTOPHAN ASSOCIATED WITH EOSINOPHILIA-MYALGIA-SYNDROME, Chemical research in toxicology, 11(3), 1998, pp. 234-240
On-line HPLC/electrospray ionization-tandem mass spectrometry (LC/ESI-
MS/MS) in conjunction with NMR has been successfully employed to ident
ify and structurally characterize seven contaminants found in three di
fferent commercial preparations of melatonin. Six of these contaminant
s were identified as analogues of impurities found in contaminated L-t
ryptophan (an over-the-counter dietary supplement) associated with the
eosinophilia-myalgia syndrome (EMS) epidemic that. occurred in the Un
ited States during 1989, In particular, our studies identified two com
pounds with MH+ = 249 to be hydroxymelatonin isomers. Four other compo
unds with MH+ = 477 were identified as melatonin-formaldehyde condensa
tion products, These compounds are structural analogues of L-tryptopha
n contaminants, namely, 'peak C' and 'peak E' that were previously imp
licated as etiological agents causing EMS. It has been reported that m
elatonin consumption has resulted in eosinophilia in some humans takin
g high doses of this supplement. Although there has not been a major o
utbreak of EMS-like symptoms from consumption of melatonin, this study
clearly suggests that tighter control and regulation of nutritional s
upplements sold and used as drugs is necessary.